Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long‐Term Safety Data from the German BIKER Registry-Reference-Cited by-同舟云学术

Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long‐Term Safety Data from the German BIKER Registry

Published:2019-11-24 Issue:1 Volume:2 Page:37-47
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Klein Ariane¹^ORCID,Becker Ingrid²,Minden Kirsten³,Hospach Anton⁴,Schwarz Tobias⁵,Foeldvari Ivan⁶,Huegle Boris⁷^ORCID,Borte Michael⁸,Weller‐Heinemann Frank⁹,Dressler Frank¹⁰,Kuemmerle‐Deschner Jasmin¹¹,Oommen Prasad Thomas¹²,Foell Dirk¹³^ORCID,Trauzeddel Ralf¹⁴,Rietschel Christoph¹⁵,Horneff Gerd¹

Affiliation:

1. Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, and University of Cologne Cologne Germany

2. University of Cologne Cologne Germany

3. German Rheumatism Research Centre Berlin, Berlin and Charité University Medicine Berlin Germany

4. Olga Hospital Stuttgart Germany

5. St. Josef‐Stift Sendenhorst Sendenhorst Germany

6. Hamburg Centre for Pediatric and Adolescent Rheumatology Hamburg Germany

7. German Centre for Pediatric and Adolescent Rheumatology Garmisch‐Partenkirchen Germany

8. Children's Hospital Sankt Georg Leipzig Germany

9. Prof. Hess Children's Hospital Bremen Germany

10. Hanover Medical School Hanover Germany

11. University Hospital Tuebingen Tübingen Germany

12. University Hospital Düsseldorf Düsseldorf Germany

13. University Children's Hospital Münster Münster Germany

14. Helios Klinik Berlin‐Buch Berlin Germany

15. Clementine Children's Hospital Frankfurt Germany

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11091

Reference22 articles.

1. Epidemiology of juvenile idiopathic arthritis in Alsace, France;Danner S;J Rheumatol,2006

2. Health care provision in pediatric rheumatology in Germany–national rheumatologic database;Minden K;J Rheumatol,2002

3. Interdisziplinäre S2-Therapieleitlinie der Juvenilen Idiopathischen Arthritis (2. Auflage)

4. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

5. The German etanercept registry for treatment of juvenile idiopathic arthritis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review;Modern Rheumatology;2024-05-25

2. Adverse events of biological agents in pediatric rheumatologic diseases;Postgraduate Medicine;2024-02-17

3. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry;Rheumatology;2024-01-18

4. Juvenile Idiopathic Arthritis;Pediatrics in Review;2023-10-01

5. Outcome of adult patients with JIA treated with the biosimilar Benepali®: results of the biologic register JuMBO;Arthritis Research & Therapy;2022-12-13